For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the emergence of Tafamidis and the formulated version represents a true breakthrough . These innovative therapies stabilize the transthyretin protein, halting its damaging build-up and lessening the burden of the disease . Individuals are now reporti… Read More